{"id":"W2137990944","doi":"10.1186/1756-8722-3-8","title":"From basic research to clinical development of MEK1/2 inhibitors for cancer therapy","year":2010,"lang":"en","type":"review","venue":"Journal of Hematology & Oncology","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":244,"is_retracted":false,"has_abstract":true,"ca_institutions":"Université de Montréal; Institute for Research in Immunology and Cancer","funders":"National Cancer Institute; Canadian Institutes of Health Research; Cancer Research Society","keywords":"Cancer research; Regulator; Cancer; Kinase; Receptor tyrosine kinase; MAPK/ERK pathway; Hematology; Tyrosine kinase; Signal transduction; Function (biology); Hyperactivation; Medicine; Biology; Internal medicine; Cell biology; Gene; Biochemistry","routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001049373,0.0009451835,0.001263654,0.001701244,0.0002813256,0.001116079,0.0009465746,0.001341631,0.004546742],"category_scores_gemma":[0.0006772407,0.0003850046,0.0004505317,0.001215953,0.0008129679,0.001462073,0.0006789523,0.00290552,0.003960428],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001046653,"about_ca_system_score_gemma":0.001000258,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0005461249,"about_ca_topic_score_gemma":0.001102282,"domain_scores_codex":[0.9997777,0.00004680254,0.00002678928,0.00003871491,0.00008373235,0.00002610278],"domain_scores_gemma":[0.999726,0.0001078726,0.00003426426,0.00001342856,0.00007500208,0.00004337335],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.000150344,0.0001962789,0.0001474561,0.005768194,0.00005409776,0.0004109926,0.00006022737,0.0005443796,0.007499758,0.006980933,0.03286172,0.9453256],"study_design_scores_gemma":[0.00007705846,0.0002335597,0.0006099435,0.001421785,0.00005206429,0.001586603,0.00002945568,0.0001788283,0.002434534,0.003362255,0.9899961,0.00001784517],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.0004498267,0.9935092,0.000831885,0.001325656,0.0003862174,0.00002323323,0.00003068507,0.00003067518,0.003412601],"genre_scores_gemma":[0.002125588,0.9940251,0.0009546238,0.0007599545,0.0004065323,0.0000277471,0.00004348877,0.000005056626,0.001651969],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.004546742,"threshold_uncertainty_score":0.01521033,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.233354112101503,"score_gpt":0.5308665528212848,"score_spread":0.2975124407197818,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}